CSL vs RMD
Side-by-side comparison of CSL Ltd and Resmed Inc — key metrics, sector exposure, and performance analysis.
Health Care
CSLCSL Ltd
A$138.50
-44.8% 1Y
CSL is a global biotechnology leader focused on plasma-derived therapies, vaccines, and specialty biologics.
Health Care
RMDResmed Inc
A$32.13
-12.4% 1Y
ResMed Inc (RMD) is a global leader in respiratory therapies and sleep apnea solutions, operating worldwide with a strong presence in Australia. Key products include CPAP (Continuous Positive Airway Pressure) machines like AirSense and AirFit masks. The company is headquartered in San Diego, USA, but listed on the ASX.
Head-to-Head Comparison
| Metric | CSL | RMD |
|---|---|---|
| Share Price | A$138.50 | A$32.13 |
| Market Cap | A$65.3B | A$46.8B |
| Daily Change | +2.88% | -0.46% |
| 1Y Performance | -44.8% | -12.4% |
| Volume | 4.16M | 1.04M |
| 52W High | A$275.79 | A$45.25 |
| 52W Low | A$133.35 | A$32.04 |
| P/E Ratio | 32.93 | 22.48 |
| Dividend Yield | 3.08% | 0.77% |
| EPS | A$4.0883 | A$10.1162 |
Summary
CSL (CSL Ltd) operates in the Health Care sector with a market capitalisation of A$65.3B. The stock has declined 44.8% over the past year.
RMD (Resmed Inc) operates in the Health Care sector with a market capitalisation of A$46.8B. The stock has declined 12.4% over the past year.
Both stocks operate in the Health Care sector, making this a direct peer comparison for investors evaluating sector allocation.